Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Johnson MC, Wang B, Tisch R.

Hum Vaccin. 2011 Jan 1;7(1):27-36. Epub 2011 Jan 1. Review.

2.

Type 1 diabetes vaccine development: animal models vs. humans.

Boettler T, von Herrath M.

Hum Vaccin. 2011 Jan 1;7(1):19-26. Epub 2011 Jan 1. Review.

PMID:
21157185
3.

Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.

Keselowsky BG, Xia CQ, Clare-Salzler M.

Hum Vaccin. 2011 Jan 1;7(1):37-44. Epub 2011 Jan 1. Review. No abstract available.

4.

Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.

Fändrich F, Ungefroren H.

Adv Exp Med Biol. 2010;654:641-65. doi: 10.1007/978-90-481-3271-3_28. Review.

PMID:
20217518
5.

Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes.

Maurice Morillon Y 2nd, Martin A, Gojanovich G, Wang B, Tisch R.

Arch Immunol Ther Exp (Warsz). 2015 Aug;63(4):239-50. doi: 10.1007/s00005-015-0336-z. Epub 2015 Mar 20. Review.

PMID:
25790749
6.

Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Chen W, Xie A, Chan L.

Transl Res. 2013 Apr;161(4):217-29. doi: 10.1016/j.trsl.2012.12.017. Epub 2013 Jan 22. Review.

7.

Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.

Staeva-Vieira T, Peakman M, von Herrath M.

Clin Exp Immunol. 2007 Apr;148(1):17-31. Review. Erratum in: Clin Exp Immunol. 2007 Jul;149(1):203.

8.

Immunotherapy for the prevention and treatment of type 1 diabetes.

Goudy KS, Tisch R.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):307-26. Review.

PMID:
16318984
9.

Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.

Azam A, Eisenbarth GS.

Expert Opin Biol Ther. 2004 Oct;4(10):1569-75. Review.

PMID:
15461568
10.

Disease-modifying immunotherapy for the management of autoimmune diabetes.

Castro CN, Barcala Tabarrozi AE, Noguerol MA, Liberman AC, Dewey RA, Arzt E, Morelli AE, Perone MJ.

Neuroimmunomodulation. 2010;17(3):173-6. doi: 10.1159/000258716. Epub 2010 Feb 4. Review.

PMID:
20134195
11.

Immunologic "vaccination" for the prevention of autoimmune diabetes (type 1A).

Simone EA, Wegmann DR, Eisenbarth GS.

Diabetes Care. 1999 Mar;22 Suppl 2:B7-15. Review.

PMID:
10097893
12.

The potential role of dendritic cells in the therapy of Type 1 diabetes.

Lee CN, Lew AM, Wu L.

Immunotherapy. 2013 Jun;5(6):591-606. doi: 10.2217/imt.13.48. Review.

PMID:
23725283
13.

Vaccines to prevent and treat autoimmune diseases.

Mor F, Cohen IR.

Int Arch Allergy Immunol. 1995 Dec;108(4):345-9. Review.

PMID:
7580306
14.

Prevention of type 1 diabetes.

Rabinovitch A, Skyler JS.

Med Clin North Am. 1998 Jul;82(4):739-55. Review.

PMID:
9706119
15.

Rational development of antigen-specific therapies for type 1 diabetes.

Fousteri G, Bresson D, von Herrath M.

Adv Exp Med Biol. 2007;601:313-9. Review.

PMID:
17713020
16.

Specific antigen vaccination to treat autoimmune disease.

McDevitt H.

Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14627-30. Epub 2004 Oct 4. Review.

17.

Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells.

Bluestone JA, Tang Q.

Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14622-6. Epub 2004 Aug 20. Review.

18.

Treg vaccination in autoimmune type 1 diabetes.

Serr I, Weigmann B, Franke RK, Daniel C.

BioDrugs. 2014 Feb;28(1):7-16. Review.

PMID:
23959795
19.

Vaccines for multiple sclerosis: progress to date.

Correale J, Farez M, Gilmore W.

CNS Drugs. 2008;22(3):175-98. Review.

PMID:
18278975
20.

Pancreatic islet autoimmunity.

Boitard C.

Presse Med. 2012 Dec;41(12 P 2):e636-50. doi: 10.1016/j.lpm.2012.10.003. Epub 2012 Nov 22. Review.

PMID:
23182678

Supplemental Content

Support Center